» Articles » PMID: 16565248

Glomerulotubular Junction Abnormalities Are Associated with Proteinuria in Type 1 Diabetes

Overview
Specialty Nephrology
Date 2006 Mar 28
PMID 16565248
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Glomerulotubular junction abnormalities, frequent in proteinuric patients with type 1 diabetes, may contribute to the progressive GFR loss in overt diabetic nephropathy. Glomerulotubular junction abnormalities were examined in patients who have type 1 diabetes with a wide range of albumin excretion rates (AER). Renal biopsies from five normoalbuminuric patients, five microalbuminuric patients, six proteinuric patients, and five control subjects were studied by light and electron microscopy. Light microscopy specimens were serially sectioned to find and classify glomerulotubular junctions. Glomerular structural parameters were estimated using stereologic methods. Glomerulotubular junction abnormalities were found in 2% of glomeruli from control and normoalbuminuric patients and in 4% of glomeruli from microalbuminuric patients. In contrast, 71% of glomeruli from proteinuric patients had glomerulotubular junction abnormalities, including five (8%) atubular glomeruli. Electron microscopy findings were typical of diabetic nephropathy. Piece-wise linear regression models with glomerular, glomerulotubular junction, and interstitial parameters as independent variables provided greater GFR (92%; P < 0.005) and AER (95%; P < 0.01) prediction than multiple regression models (81% for GFR and 72% for AER). Thus, glomerular adhesions and glomerulotubular junction abnormalities help to explain the progressive GFR loss that is associated with onset of proteinuria in type 1 diabetes. Moreover, nonlinear models provide better fit for structural-functional relationships in patients with type 1 diabetes.

Citing Articles

Albuminuria and Rapid Kidney Function Decline as Selection Criteria for Kidney Clinical Trials in Type 1 Diabetes Mellitus.

Keum Y, Caramori M, Cherney D, Crandall J, de Boer I, Lingvay I Clin J Am Soc Nephrol. 2024; 20(1):62-71.

PMID: 39423023 PMC: 11737443. DOI: 10.2215/CJN.0000000000000567.


Parallelism and non-parallelism in diabetic nephropathy and diabetic retinopathy.

Tang S, An X, Sun W, Zhang Y, Yang C, Kang X Front Endocrinol (Lausanne). 2024; 15:1336123.

PMID: 38419958 PMC: 10899692. DOI: 10.3389/fendo.2024.1336123.


Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia.

Viggiano D J Clin Med. 2023; 12(21).

PMID: 37959313 PMC: 10650633. DOI: 10.3390/jcm12216848.


KDOQI US Commentary on the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD.

Mottl A, Alicic R, Argyropoulos C, Brosius F, Mauer M, Molitch M Am J Kidney Dis. 2022; 79(4):457-479.

PMID: 35144840 PMC: 9740752. DOI: 10.1053/j.ajkd.2021.09.010.


Magnetic resonance imaging accurately tracks kidney pathology and heterogeneity in the transition from acute kidney injury to chronic kidney disease.

Charlton J, Xu Y, Wu T, deRonde K, Hughes J, Dutta S Kidney Int. 2020; 99(1):173-185.

PMID: 32916180 PMC: 8822820. DOI: 10.1016/j.kint.2020.08.021.